INmune Bio, Inc.
$2.24
-0.06 (-2.61%)
Price as of Sep 01, 2026 market close
Performance
- 1 Month
- +21.1%
- 3 Months
- +57.7%
- YTD
- +43.6%
- 1 Year
- +10.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 71.9%
- Largest decline max drawdown, since Aug 2025
- -55.7%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.49
Own INMB?
See how INMB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.